OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $568.45 million. The enterprise value is $589.56 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 24.77 million shares outstanding. The number of shares has increased by 1.87% in one year.
| Current Share Class | 24.77M |
| Shares Outstanding | 24.77M |
| Shares Change (YoY) | +1.87% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 4.92% |
| Owned by Institutions (%) | 69.87% |
| Float | 16.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.50 |
| Forward PS | 2.24 |
| PB Ratio | 1.64 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.23.
| Current Ratio | 6.19 |
| Quick Ratio | 2.74 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.88 |
Financial Efficiency
Return on equity (ROE) is -11.33% and return on invested capital (ROIC) is -4.74%.
| Return on Equity (ROE) | -11.33% |
| Return on Assets (ROA) | -4.23% |
| Return on Invested Capital (ROIC) | -4.74% |
| Return on Capital Employed (ROCE) | -7.10% |
| Revenue Per Employee | $378,030 |
| Profits Per Employee | -$72,377 |
| Employee Count | 562 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.50 |
Taxes
| Income Tax | -1.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.23% in the last 52 weeks. The beta is 1.10, so OrthoPediatrics's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -28.23% |
| 50-Day Moving Average | 23.00 |
| 200-Day Moving Average | 25.30 |
| Relative Strength Index (RSI) | 54.65 |
| Average Volume (20 Days) | 132,927 |
Short Selling Information
The latest short interest is 1.16 million, so 4.67% of the outstanding shares have been sold short.
| Short Interest | 1.16M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 4.67% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 7.22 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $212.45 million and -$40.68 million in losses. Loss per share was -$1.76.
| Revenue | 212.45M |
| Gross Profit | 154.69M |
| Operating Income | -30.74M |
| Pretax Income | -27.03M |
| Net Income | -40.68M |
| EBITDA | -11.64M |
| EBIT | -30.74M |
| Loss Per Share | -$1.76 |
Full Income StatementBalance Sheet
The company has $58.77 million in cash and $79.88 million in debt, giving a net cash position of -$21.11 million or -$0.85 per share.
| Cash & Cash Equivalents | 58.77M |
| Total Debt | 79.88M |
| Net Cash | -21.11M |
| Net Cash Per Share | -$0.85 |
| Equity (Book Value) | 347.15M |
| Book Value Per Share | 13.98 |
| Working Capital | 194.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.51 million and capital expenditures -$12.03 million, giving a free cash flow of -$36.54 million.
| Operating Cash Flow | -24.51M |
| Capital Expenditures | -12.03M |
| Free Cash Flow | -36.54M |
| FCF Per Share | -$1.48 |
Full Cash Flow StatementMargins
Gross margin is 72.81%, with operating and profit margins of -14.47% and -19.15%.
| Gross Margin | 72.81% |
| Operating Margin | -14.47% |
| Pretax Margin | -19.80% |
| Profit Margin | -19.15% |
| EBITDA Margin | -5.48% |
| EBIT Margin | -14.47% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.87% |
| Shareholder Yield | -1.87% |
| Earnings Yield | -7.16% |
| FCF Yield | -6.43% |
Analyst Forecast
The average price target for OrthoPediatrics is $35.71, which is 55.40% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.71 |
| Price Target Difference | 55.40% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 3.25 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.25 |
| Piotroski F-Score | 3 |